Assessment of Progressive Lens Designs (TBPD)
Primary Purpose
Presbyopia
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Sponsored by
About this trial
This is an interventional other trial for Presbyopia focused on measuring presbyopia, progressive addition lenses
Eligibility Criteria
Inclusion Criteria:
- Subjects should be experienced progressive lens designs wearers who have worn their current prescription for at least the last one month.
- PAL wearers with 14 mm corridor
- Age: 45 to 70 years old
- Best Corrected Monocular visual Acuity (decimal) both at distance and near ≥ 1.0;
Normal binocular vision at distance & near:
- no strabismus on cover test,
- no fixation disparity (Mallett aligning prism of less than 2Δ horizontally or vertically) at near
- stereoacuity of 60" or better at near;
New prescription (found at visit #1) is in the range:
- Spherical power: up to +/-6.00;
- Cylindrical power: minus cylinder ≤ 2.5D;
- Addition: 1.50-2.50D;
- Difference in the power (spherical equivalent) between eyes: up to 2.0D
- Understanding and speaking Italian or English to be able to answer questionnaires
- Giving a written consent to participate in the study
Exclusion Criteria:
- First prescription for progressive lenses.
- Prescription found during visit#1 varies from current prescription more than 0.50D in any meridian
- Wearing Single Vision lenses with accommodative support
- Double vision or prismatic prescription in current glasses;
- Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity
- Use of systemic or ocular medications that are likely to affect vision
- Balance problem/vertigo problem
- Concurrent participation in other vision-related research
Sites / Locations
- Optics and Optometry of Milano-Bicocca (COMiB), Department of Materials Science - University of Milano-Bicocca
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
The specified PAL design wearers
The other PAL design wearers
Arm Description
Subjects who have been already wearing any from specified design type of PAL
Subjects who have been already wearing any from the other design type of PAL
Outcomes
Primary Outcome Measures
Evaluate the preference among progressive lens designs
Evaluate the preference among progressive lens designs through a "First impression questionnaire" after 10-15 minutes of wearing each of the 3 PALs, a "Final satisfaction questionnaire" after 1 week of use of each of the 3 PALs and a "Comparison questionnaire" at the end of the three trial periods of all the three types of PALs.
Secondary Outcome Measures
Evaluate the adaptability of progressive lens designs.
Evaluate adaptability of progressive lens designs through a "Final satisfation questionnaire" after one week of use of each of the three PALs.
Evaluate visual performance of progressive lens designs.
Evaluate the visual performance of progressive lens designs measured both after 10-15 minutes of wear and after one week by psychophysical analysis (visual acuity at high contrast at near and at distance, rate/accuracy of reading test at high contrast and at near).
Full Information
NCT ID
NCT04734522
First Posted
January 15, 2021
Last Updated
September 28, 2021
Sponsor
University of Milano Bicocca
Collaborators
HOYA Corporation Vision Care
1. Study Identification
Unique Protocol Identification Number
NCT04734522
Brief Title
Assessment of Progressive Lens Designs
Acronym
TBPD
Official Title
Assessment of Progressive Lens Designs
Study Type
Interventional
2. Study Status
Record Verification Date
September 2021
Overall Recruitment Status
Completed
Study Start Date
October 19, 2020 (Actual)
Primary Completion Date
August 31, 2021 (Actual)
Study Completion Date
September 20, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Milano Bicocca
Collaborators
HOYA Corporation Vision Care
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Non-invasive double-blind randomised comparative study on presbyopic subjects wearing progressive lenses.
Detailed Description
Background and rationale:
Nowadays many different types of progressive addition lenses are available for the correction of presbyopia. Progressive addition lenses provide a more natural correction for presbyopic people due to a gradual and progressive increase of lens power from far area through the intermediate portion to the near area. However, some patients still experience adaptation problems.
The primary purpose of the study is to evaluate the preference, adaptability and visual performance of progressive lens designs (up to three designs).
Study procedures:
Each participant is required to wear all pairs of spectacles one after another, each pair for one week.
Each participant will be required to visit the optometry clinic (at University of Milano Bicocca) three times:
Visit #1: Screening based on inclusion criteria, Informed Consent Form (ICF) form signing, Optometric exam and choice of the frame.
Subjects who will pass the inclusion/exclusion screening will be asked to sign the ICF and enrolled for the optometric exam. Subjects will choose the spectacle frame and all individual fitting parameters will be measured for lens' manufacturing.
Visit #2: Subjects will receive three marked pairs of progressive lenses. The three spectacle frames will be adjusted to fit properly on the subject' face. After 10-15 min of wearing of the first pair of lenses, each subject will be asked to answer to a questionnaire.
Visit #3 (last visit): questionnaires should be returned; the last comparison question will be answered during this visit, and subject will choose the best pair.
At the end of the study each participant will be entitled to get one pair of progressive lenses available in the market.
Subject population:
Presbyopic subjects have been already wearing any progressive additional lens (PAL) designs.
Number of Subjects:
40 +/- 2 subjects, the specified PAL design wearers and 40 +/- 2 the other PAL design wearers to be enrolled and signed the informed consent form.
Each subject will be wearing three different PAL designs. Subjects will be asked to choose one pair of spectacles (design) which they like the most.
Randomisation:
This study adopts a stratified permuted block randomisation to reduce an evaluation bias by the wearing sequence and prescriptions. The mean of both eyes' prescriptions is set as a single stratification factor.
Frames:
Each subject will choose a model of spectacle frame. Three identical frames will be taken for each subject.
Lenses:
Lenses will be produced in EU
Three different lens designs will be tested in the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Presbyopia
Keywords
presbyopia, progressive addition lenses
7. Study Design
Primary Purpose
Other
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
80 (Actual)
8. Arms, Groups, and Interventions
Arm Title
The specified PAL design wearers
Arm Type
Experimental
Arm Description
Subjects who have been already wearing any from specified design type of PAL
Arm Title
The other PAL design wearers
Arm Type
Active Comparator
Arm Description
Subjects who have been already wearing any from the other design type of PAL
Intervention Type
Device
Intervention Name(s)
Progressive Additional Lenses (PAL), pre calibrated and made of polymeric material with anti-reflection coating
Intervention Description
Subjects will be wearing three different PAL designs with different geometries of the optical progression.
Primary Outcome Measure Information:
Title
Evaluate the preference among progressive lens designs
Description
Evaluate the preference among progressive lens designs through a "First impression questionnaire" after 10-15 minutes of wearing each of the 3 PALs, a "Final satisfaction questionnaire" after 1 week of use of each of the 3 PALs and a "Comparison questionnaire" at the end of the three trial periods of all the three types of PALs.
Time Frame
Entire study duration (approx. 4 weeks)
Secondary Outcome Measure Information:
Title
Evaluate the adaptability of progressive lens designs.
Description
Evaluate adaptability of progressive lens designs through a "Final satisfation questionnaire" after one week of use of each of the three PALs.
Time Frame
Entire study duration (approx. 4 weeks)
Title
Evaluate visual performance of progressive lens designs.
Description
Evaluate the visual performance of progressive lens designs measured both after 10-15 minutes of wear and after one week by psychophysical analysis (visual acuity at high contrast at near and at distance, rate/accuracy of reading test at high contrast and at near).
Time Frame
Entire study duration (approx. 4 weeks)
10. Eligibility
Sex
All
Minimum Age & Unit of Time
45 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Subjects should be experienced progressive lens designs wearers who have worn their current prescription for at least the last one month.
PAL wearers with 14 mm corridor
Age: 45 to 70 years old
Best Corrected Monocular visual Acuity (decimal) both at distance and near ≥ 1.0;
Normal binocular vision at distance & near:
no strabismus on cover test,
no fixation disparity (Mallett aligning prism of less than 2Δ horizontally or vertically) at near
stereoacuity of 60" or better at near;
New prescription (found at visit #1) is in the range:
Spherical power: up to +/-6.00;
Cylindrical power: minus cylinder ≤ 2.5D;
Addition: 1.50-2.50D;
Difference in the power (spherical equivalent) between eyes: up to 2.0D
Understanding and speaking Italian or English to be able to answer questionnaires
Giving a written consent to participate in the study
Exclusion Criteria:
First prescription for progressive lenses.
Prescription found during visit#1 varies from current prescription more than 0.50D in any meridian
Wearing Single Vision lenses with accommodative support
Double vision or prismatic prescription in current glasses;
Known ocular disease including strabismus, any pathology, any eye surgeries that may affect visual acuity
Use of systemic or ocular medications that are likely to affect vision
Balance problem/vertigo problem
Concurrent participation in other vision-related research
Facility Information:
Facility Name
Optics and Optometry of Milano-Bicocca (COMiB), Department of Materials Science - University of Milano-Bicocca
City
Milano
ZIP/Postal Code
20126
Country
Italy
12. IPD Sharing Statement
Learn more about this trial
Assessment of Progressive Lens Designs
We'll reach out to this number within 24 hrs